TABLE 3.
Survey respondent demographic and clinical characteristics by interest in de‐escalation trial participation (N = 91)
| Total | Interested in de‐escalation trial | Uninterested in de‐escalation trial | Effect size | |
|---|---|---|---|---|
| N = 91 | n = 52 | n = 39 | ||
| n (%) | n (%) | n (%) | V | |
| Age (median, IQR) | 58 (48–66) | 60 (51–70) | 55 (45–69) | d = 0.21 |
| Race | 0.02 | |||
| White | 69 (75.8) | 39 (56.5) | 30 (43.5) | |
| Other race | 22 (24.2) | 13 (59.1) | 9 (40.9) | |
| Ethnicity | 0.09 | |||
| Hispanic or Latino | 10 (11.0) | 7 (70.0) | 3 (30.0) | |
| Non‐Hispanic or Latino | 81 (89.0) | 45 (55.6) | 36(44.4) | |
| Annual household income | 0.08 | |||
| ≥$40,000 | 47 (51.7) | 25 (53.2) | 22 (46.8) | |
| <$40,000 | 44 (48.4) | 27 (61.4) | 17 (38.6) | |
| Marital status | 0.23 | |||
| Single/divorced/widowed | 44 (48.4) | 20 (45.5) | 24(54.6) | |
| Married | 47 (51.7) | 32 (68.1) | 15 (31.9) | |
| Employment status | 0.17 | |||
| Working | 42 (46.2) | 23 (54.8) | 19 (45.2) | |
| Retired | 24 (26.4) | 16 (66.7) | 8 (33.3) | |
| On disability | 18 (19.8) | 8 (44.4) | 10 (55.6) | |
| Unemployed/not working | 7 (7.7) | 5 (71.4) | 2 (28.6) | |
| Health insurance status | 0.11 | |||
| Private | 47 (51.7) | 29 (61.7) | 18 (38.3) | |
| Medicare | 39 (42.9) | 20 (51.3) | 19 (48.7) | |
| Medicaid | 2 (2.2) | 1 (50.0) | 1 (50.0) | |
| Uninsured/unknown | 3 (3.3) | 2 (66.7) | 1 (33.3) | |
| Breast cancer diagnosis stage | 0.18 | |||
| 0 | 3 (3.3) | 1 (33.3) | 2 (66.7) | |
| I | 19 (20.9) | 11 (57.9) | 8 (42.1) | |
| II | 40 (44.0) | 21 (52.5) | 19 (47.5) | |
| III | 16 (17.6) | 10 (62.5) | 6 (37.5) | |
| IV | 9 (9.9) | 7 (77.8) | 2 (22.2) | |
| Unknown | 4 (4.4) | 2 (50.0) | 2 (50.0) | |
| Years from diagnosis | 0.11 | |||
| <1–2 | 30 (33.0) | 17 (56.7) | 13 (43.3) | |
| 3–4 | 28 (30.8) | 18 (64.3) | 10 (35.7) | |
| 5+ | 33 (36.3) | 17 (51.5) | 16 (48.5) | |
| Cancer recurrence | 40 (44.0) | 24 (60.0) | 16 (40.0) | 0.05 |
| On active treatment | 58 (63.7) | 31 (53.5) | 27 (46.6) | 0.10 |
Abbreviation: IQR, interquartile range.